Durgical
EN
Open the app

Rizatriptan

  • Triptans (5-HT1B/1D agonists)Triptans (5-HT1B/1D agonists)

A fast oral triptan, also as an orally disintegrating tablet, for migraine attacks; propranolol raises its levels and MAO inhibitors are excluded.

Updated

Also called: Rizatriptan benzoate

Quick facts

Group
Triptans (5-HT1B/1D agonists)
Target
Serotonin 5-HT1B and 5-HT1D receptors
Used for
Acute treatment of migraine
Key effects
Weakness or tiredness · Sensations of pain or pressure
Monitor
Cardiovascular evaluation · Blood pressure
ATC
N02CC04

No doses: the clinician sets them by the current guideline.

Mechanism of action

The figure shows donitriptan, an experimental triptan, in the serotonin-binding pocket of the human 5-HT1B receptor; rizatriptan binds the same pocket.

Target in 3D: Serotonin 5-HT1B and 5-HT1D receptors. PDB structure 6G79 (RCSB PDB, public domain). View the structure at RCSB PDB

Rizatriptan is a 5-HT1B/1D receptor agonist. It constricts intracranial vessels and reduces the release of inflammatory neuropeptides from trigeminal nerve endings, relieving the headache and associated nausea and light sensitivity of an attack.

  1. Rizatriptan activates 5-HT1B/1D receptors
  2. Intracranial vessels constrict; trigeminal endings quiet down
  3. Headache and associated symptoms improve

Indications

  • Acute treatment of migraine with or without aura in adults and children 6 to 17 years old Migraine →

Adverse effects

Common

  • Weakness or tiredness, drowsiness and dizziness
  • Sensations of pain or pressure (chest, throat, neck or jaw)

Contraindications

  • Ischaemic coronary artery disease or coronary vasospasm (including Prinzmetal angina)
  • History of stroke or TIA; hemiplegic or basilar migraine
  • Peripheral vascular disease and ischaemic bowel disease
  • Uncontrolled hypertension
  • Another triptan or an ergot alkaloid in the previous 24 hours
  • An MAO-A inhibitor now or in the past 2 weeks
  • Hypersensitivity to rizatriptan or excipients

Key interactions

Propranolol
Raises rizatriptan levels (by about 70%); a lower dose is used
MAO-A inhibitors
Block its metabolism; contraindicated
Ergot alkaloids or other triptans within 24 hours
Additive vasospasm; contraindicated
SSRIs, SNRIs, tricyclics
Serotonin syndrome

What is monitored

  • Cardiovascular evaluation in triptan-naive patients with several risk factors
  • Blood pressure
  • Days of acute treatment per month

Administration and safety

  • The orally disintegrating tablet dissolves on the tongue without water
  • The dose is adjusted in patients on propranolol
  • For attacks only; not a preventive

Pregnancy and breastfeeding

Human data are not sufficient to define the risk; animal studies showed developmental toxicity at high exposure.

Nursing care

  • Before the first dose, ask about chest pain, heart disease, stroke, high blood pressure and cardiovascular risk factors
  • Check the medication list for ergots, other triptans, MAO inhibitors and serotonergic antidepressants
  • Explain that chest or throat tightness is common, but crushing chest pain needs urgent care
  • Encourage a headache diary to spot medication overuse
  • Teach signs of serotonin syndrome: agitation, fever, sweating, tremor, muscle jerks

Pharmacokinetics

Absorption
Completely absorbed; bioavailability about 45%; peak in about 1 to 1.5 hours (slightly later with the orally disintegrating tablet)
Metabolism
Oxidative deamination by MAO-A
Half-life
About 2 to 3 hours

Test yourself

Think of the answer, then tap the question to see it.

Which migraine-preventive drug raises rizatriptan levels?

Propranolol.

Which enzyme mainly metabolizes rizatriptan?

MAO-A, so MAO-A inhibitors are contraindicated.

Can rizatriptan be used in children?

Yes, for acute migraine from 6 to 17 years of age.

Add to my cards (3)

More Pharmacology questions →

Connections

← Back to the class: Triptans (5-HT1B/1D agonists)

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - RIZATRIPTAN BENZOATE tablet (DailyMed (U.S. National Library of Medicine), 2026); Rizatriptan: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.